{'Year': '2008', 'Month': 'Oct', 'Day': '15'}
Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease.
To investigate whether pharmacogenetic loci or metabolite concentrations explain clinical response or side effects to AZA.